217 related articles for article (PubMed ID: 9851894)
1. alpha2-macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein.
Heeb MJ; España F
Blood Cells Mol Dis; 1998 Dec; 24(4):412-9. PubMed ID: 9851894
[TBL] [Abstract][Full Text] [Related]
2. Detection of human glandular kallikrein, hK2, as its precursor form and in complex with protease inhibitors in prostate carcinoma serum.
Grauer LS; Finlay JA; Mikolajczyk SD; Pusateri KD; Wolfert RL
J Androl; 1998; 19(4):407-11. PubMed ID: 9733142
[TBL] [Abstract][Full Text] [Related]
3. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
Charlesworth MC; Young CY; Miller VM; Tindall DJ
J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue.
Mikolajczyk SD; Millar LS; Marker KM; Rittenhouse HG; Wolfert RL; Marks LS; Charlesworth MC; Tindall DJ
Cancer Res; 1999 Aug; 59(16):3927-30. PubMed ID: 10463585
[TBL] [Abstract][Full Text] [Related]
5. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
[TBL] [Abstract][Full Text] [Related]
6. Prostate specific antigen-alpha 2-macroglobulin complexes in prostate cancer patient sera.
Heeb MJ; España F; Gittes RF; Griffin JH
Biochem Mol Biol Int; 1995 Nov; 37(5):917-23. PubMed ID: 8624498
[TBL] [Abstract][Full Text] [Related]
7. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
[TBL] [Abstract][Full Text] [Related]
8. Western blot analyses of prekallikrein and its activation products in human plasma.
Veloso D; Colman RW
Thromb Haemost; 1991 Apr; 65(4):382-8. PubMed ID: 1711719
[TBL] [Abstract][Full Text] [Related]
9. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D.
Hsieh ML; Charlesworth MC; Goodmanson M; Zhang S; Seay T; Klee GG; Tindall DJ; Young CY
Cancer Res; 1997 Jul; 57(13):2651-6. PubMed ID: 9205072
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
Mize GJ; Wang W; Takayama TK
Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
[TBL] [Abstract][Full Text] [Related]
11. Identification of human glandular kallikrein hK2 from LNCaP cells.
Grauer LS; Charlesworth MC; Saedi MS; Finlay JA; Liu RS; Kuus-Reichel K; Young CY; Tindall DJ
J Androl; 1996; 17(4):353-9. PubMed ID: 8889697
[TBL] [Abstract][Full Text] [Related]
12. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
Olson ST; Sheffer R; Francis AM
Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of kallikrein in human plasma.
van der Graaf F; Koedam JA; Bouma BN
J Clin Invest; 1983 Jan; 71(1):149-58. PubMed ID: 6184384
[TBL] [Abstract][Full Text] [Related]
14. Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer.
Stephan C; Jung K; Nakamura T; Yousef GM; Kristiansen G; Diamandis EP
Int J Urol; 2006 Mar; 13(3):238-43. PubMed ID: 16643616
[TBL] [Abstract][Full Text] [Related]
15. Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation.
Deperthes D; Frenette G; Brillard-Bourdet M; Bourgeois L; Gauthier F; Tremblay RR; Dubé JY
J Androl; 1996; 17(6):659-65. PubMed ID: 9016396
[TBL] [Abstract][Full Text] [Related]
16. Free and total human glandular kallikrein 2 in patients with prostate cancer.
Väisänen V; Pettersson K; Alanen K; Viitanen T; Nurmi M
Urology; 2006 Jul; 68(1):219-25. PubMed ID: 16844459
[TBL] [Abstract][Full Text] [Related]
17. Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors.
Mikolajczyk SD; Millar LS; Kumar A; Saedi MS
Prostate; 1998 Jan; 34(1):44-50. PubMed ID: 9428387
[TBL] [Abstract][Full Text] [Related]
18. Purification of enzymatically active kallikrein hK2 from human seminal plasma.
Frenette G; Deperthes D; Tremblay RR; Lazure C; Dubé JY
Biochim Biophys Acta; 1997 Feb; 1334(1):109-15. PubMed ID: 9042371
[TBL] [Abstract][Full Text] [Related]
19. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
Czendlik C; Lämmle B; Duckert F
Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
[TBL] [Abstract][Full Text] [Related]
20. Plasma prekallikrein assay: reversible inhibition of C-1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species.
Schmaier AH; Gustafson E; Idell S; Colman RW
J Lab Clin Med; 1984 Dec; 104(6):882-92. PubMed ID: 6209352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]